133 related articles for article (PubMed ID: 10080602)
1. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for early diagnosis of pancreatic cancer.
Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
[TBL] [Abstract][Full Text] [Related]
4. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer.
Morales E; Porta M; Vioque J; López T; Mendez MA; Pumarega J; Malats N; Crous-Bou M; Ngo J; Rifà J; Carrato A; Guarner L; Corominas JM; Real FX;
J Epidemiol Community Health; 2007 Jul; 61(7):641-9. PubMed ID: 17568059
[TBL] [Abstract][Full Text] [Related]
5. Approaches to inhibiting oncogenic K-Ras.
Gorfe AA; Cho KJ
Small GTPases; 2021 Mar; 12(2):96-105. PubMed ID: 31438765
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor DNA in early- and late-stage human malignancies.
Bettegowda C; Sausen M; Leary RJ; Kinde I; Wang Y; Agrawal N; Bartlett BR; Wang H; Luber B; Alani RM; Antonarakis ES; Azad NS; Bardelli A; Brem H; Cameron JL; Lee CC; Fecher LA; Gallia GL; Gibbs P; Le D; Giuntoli RL; Goggins M; Hogarty MD; Holdhoff M; Hong SM; Jiao Y; Juhl HH; Kim JJ; Siravegna G; Laheru DA; Lauricella C; Lim M; Lipson EJ; Marie SK; Netto GJ; Oliner KS; Olivi A; Olsson L; Riggins GJ; Sartore-Bianchi A; Schmidt K; Shih lM; Oba-Shinjo SM; Siena S; Theodorescu D; Tie J; Harkins TT; Veronese S; Wang TL; Weingart JD; Wolfgang CL; Wood LD; Xing D; Hruban RH; Wu J; Allen PJ; Schmidt CM; Choti MA; Velculescu VE; Kinzler KW; Vogelstein B; Papadopoulos N; Diaz LA
Sci Transl Med; 2014 Feb; 6(224):224ra24. PubMed ID: 24553385
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.
Kinugasa H; Nouso K; Miyahara K; Morimoto Y; Dohi C; Tsutsumi K; Kato H; Matsubara T; Okada H; Yamamoto K
Cancer; 2015 Jul; 121(13):2271-80. PubMed ID: 25823825
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.
Sausen M; Phallen J; Adleff V; Jones S; Leary RJ; Barrett MT; Anagnostou V; Parpart-Li S; Murphy D; Kay Li Q; Hruban CA; Scharpf R; White JR; O'Dwyer PJ; Allen PJ; Eshleman JR; Thompson CB; Klimstra DS; Linehan DC; Maitra A; Hruban RH; Diaz LA; Von Hoff DD; Johansen JS; Drebin JA; Velculescu VE
Nat Commun; 2015 Jul; 6():7686. PubMed ID: 26154128
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis.
Chen L; Zhang Y; Cheng Y; Zhang D; Zhu S; Ma X
Gene; 2018 Dec; 679():328-334. PubMed ID: 30227250
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.
Sefrioui D; Blanchard F; Toure E; Basile P; Beaussire L; Dolfus C; Perdrix A; Paresy M; Antonietti M; Iwanicki-Caron I; Alhameedi R; Lecleire S; Gangloff A; Schwarz L; Clatot F; Tuech JJ; Frébourg T; Jardin F; Sabourin JC; Sarafan-Vasseur N; Michel P; Di Fiore F
Br J Cancer; 2017 Sep; 117(7):1017-1025. PubMed ID: 28772284
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
12. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
[TBL] [Abstract][Full Text] [Related]
13. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A
Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
Mulcahy HE; Lyautey J; Lederrey C; qi Chen X; Anker P; Alstead EM; Ballinger A; Farthing MJ; Stroun M
Clin Cancer Res; 1998 Feb; 4(2):271-5. PubMed ID: 9516910
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Multiplex Detection of
Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
[TBL] [Abstract][Full Text] [Related]
16. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
Wang K; Wang X; Pan Q; Zhao B
Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
[TBL] [Abstract][Full Text] [Related]
18. The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer.
Maloney S; Clarke SJ; Sahni S; Hudson A; Colvin E; Mittal A; Samra J; Pavlakis N
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13437-13450. PubMed ID: 37460806
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer.
Watanabe F; Suzuki K; Noda H; Rikiyama T
World J Gastroenterol; 2022 Dec; 28(46):6478-6496. PubMed ID: 36569270
[TBL] [Abstract][Full Text] [Related]
20. Evolution of
Valladares-Ayerbes M; Garcia-Alfonso P; Muñoz Luengo J; Pimentel Caceres PP; Castillo Trujillo OA; Vidal-Tocino R; Llanos M; Llorente Ayala B; Limon Miron ML; Salud A; Cirera Nogueras L; Garcia-Carbonero R; Safont MJ; Falco Ferrer E; Aparicio J; Vicente Conesa MA; Guillén-Ponce C; Garcia-Teijido P; Medina Magan MB; Busquier I; Salgado M; Lloansí Vila A;
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]